25 May 2013
Keywords: protherics, healthy, cash, flow, after, cytofab, deal
Article | 17 April 2006
In a pre-closing statement ahead of its fiscal-year results anouncement, UK-based Protherics says its underlying business has continued to
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 April 2006
24 April 2006
24 May 2013
© 2013 thepharmaletter.com